Day'Ron Sharpe: Everything you need to know

Day'Ron Sharpe

#20 C

Brooklyn Nets

Status

OUT - Thumb - Surgery Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

7.0

5.9

1.5

0.6

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	62	7	18.7	8.7	6.7	2.3	0.4	1.1	1.7	5	0.1	0.6	23.1%	3.3	5.1	64.7%	3.5	5.7	60.1%	1.7	2.5	67.8%	2.8	3.9	2.4	1.4	-114	63.8%
2024-25	50	2	18.1	7.9	6.6	1.8	0.8	0.8	1.3	4	0.2	0.9	24.4%	3.1	5.4	56.6%	3.3	6.3	52.1%	1.1	1.5	75.7%	3.0	3.6	2.3	1.4	+64	56.8%
2023-24	61	1	15.1	6.8	6.4	1.4	0.7	0.4	1.1	6	0.1	0.2	26.7%	2.7	4.6	58.8%	2.8	4.8	57.1%	1.2	2.0	61.0%	2.6	3.7	2.1	1.2	+64	59.6%
2022-23	48	3	11.5	4.7	4.2	0.8	0.7	0.3	0.9	2	0.1	0.2	54.5%	1.8	3.3	54.4%	1.9	3.6	54.4%	0.7	1.1	63.6%	2.1	2.1	1.9	0.9	-101	58.1%
2021-22	32	8	12.2	6.2	5.0	0.5	0.5	0.3	0.9	2	0.1	0.2	28.6%	2.6	4.4	59.2%	2.7	4.7	57.7%	0.8	1.3	58.5%	2.5	2.5	1.9	0.6	+57	59.3%
Career	253	21	15.5	7.0	5.9	1.5	0.6	0.6	1.2	19	0.1	0.5	27.4%	2.7	4.6	59.3%	2.9	5.1	56.4%	1.2	1.8	65.8%	2.6	3.3	2.1	1.2	-30	59.9%

Career Averages

PTS

REB

AST

BLK

STL

2.0

1.7

0.3

0.0

Year	GP	MIN	PTS	REB	AST	BLK	TO	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2022-23	2	10.0	3.0	3.0	2.5	0.5	1.0	0.0%	1.0	1.5	66.7%	1.0	1.5	66.7%	1.0	1.0	100.0%	1.0	2.0	1.5	2.5	-9	77.3%
2021-22	1	0.0	0.0	0.0	0.0	0.0	0.0	0.0%	0.0	0.0	0.0%	0.0	0.0	0.0%	0.0	0.0	0.0%	0.0	0.0	0.0	0.0	+2	0.0%
Career	3	6.7	2.0	2.0	1.7	0.3	0.7	0.0%	0.7	1.0	66.7%	0.7	1.0	66.7%	0.7	0.7	100.0%	0.7	1.3	1.0	2.5	-7	77.3%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/12	PHX	W 111-109	18	7	7	1	0	1	2	0	0	0.0%	3	1	33.3%	3	1	33.3%	6	5	83.3%	1	6	0.5	-5	1	13	62.1%
10/10	PHX	L 132-127	19	8	7	1	0	2	2	0	0	0.0%	6	3	50.0%	6	3	50.0%	3	2	66.7%	5	2	0.5	-11	3	13	54.6%
10/4	HAP	W 123-88	14	7	5	1	2	0	1	1	1	100.0%	4	2	50.0%	5	3	60.0%	0	0	0.0%	2	3	1.0	+18	2	10	70.0%
Preseason Totals			17.4	7.3	6.3	1.0	0.7	1.0	1.7	0.3	0.3	100.0%	4.3	2.0	46.2%	4.7	2.3	50.0%	3.0	2.3	77.8%	2.7	3.7	0.6	+2	2.0	15.0	61.2%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
3/9	MEM	W 126-115	17	19	5	2	1	2	2	1	1	100.0%	10	7	70.0%	11	8	72.7%	2	2	100.0%	3	2	1.0	+16	3	21	80.0%
3/7	DET	W 107-105	21	13	7	4	0	2	3	1	1	100.0%	9	5	55.6%	10	6	60.0%	0	0	0.0%	3	4	1.3	+6	2	16	65.0%
3/5	MIA	L 126-110	17	7	5	1	0	0	2	1	0	0.0%	5	3	60.0%	6	3	50.0%	2	1	50.0%	4	1	0.5	-8	4	4	50.9%
3/3	MIA	L 124-98	17	10	8	4	0	0	0	0	0	0.0%	6	5	83.3%	6	5	83.3%	0	0	0.0%	4	4	0.0	-6	2	19	83.3%
3/1	CLE	L 106-102	28	7	8	3	1	1	6	1	0	0.0%	4	3	75.0%	5	3	60.0%	2	1	50.0%	0	8	0.5	-7	5	8	59.5%
2/27	BOS	L 148-111	14	2	5	3	0	0	1	1	0	0.0%	6	1	16.7%	7	1	14.3%	0	0	0.0%	2	3	3.0	-14	3	2	14.3%
2/26	SAS	L 126-110	19	14	11	4	1	1	3	1	0	0.0%	9	6	66.7%	10	6	60.0%	2	2	100.0%	5	6	1.3	-9	2	25	64.3%
2/24	DAL	L 123-114	15	7	2	1	0	1	2	0	0	0.0%	7	3	42.9%	7	3	42.9%	2	1	50.0%	1	1	0.5	-15	3	2	44.4%
2/22	ATL	L 115-104	17	11	5	2	1	2	3	0	0	0.0%	6	4	66.7%	6	4	66.7%	4	3	75.0%	3	2	0.7	+8	0	18	70.9%
2/20	OKC	L 105-86	27	12	8	2	1	2	2	0	0	0.0%	8	6	75.0%	8	6	75.0%	2	0	0.0%	2	6	1.0	-12	4	15	67.6%
2/19	CLE	L 112-84	19	4	5	3	0	0	0	1	0	0.0%	4	1	25.0%	5	1	20.0%	2	2	100.0%	4	1	0.0	-28	1	8	34.0%
2/11	IND	L 115-110	30	19	12	5	2	2	1	0	0	0.0%	11	8	72.7%	11	8	72.7%	4	3	75.0%	5	7	5.0	+12	1	39	74.5%
2/9	CHI	W 123-115	15	6	7	0	0	0	2	1	0	0.0%	7	2	28.6%	8	2	25.0%	4	2	50.0%	4	3	0.0	-9	4	0	30.7%
2/7	WAS	W 127-113	19	19	9	4	0	2	3	0	0	0.0%	11	9	81.8%	11	9	81.8%	1	1	100.0%	4	5	1.3	+26	4	26	83.0%
2/5	ORL	L 118-98	13	4	5	0	0	1	1	0	0	0.0%	4	2	50.0%	4	2	50.0%	0	0	0.0%	2	3	0.0	-6	4	5	50.0%
2/3	LAL	L 125-109	25	19	14	5	0	3	1	0	0	0.0%	12	9	75.0%	12	9	75.0%	1	1	100.0%	10	4	5.0	+14	4	34	76.4%
2/1	DET	L 130-77	22	8	11	0	0	0	5	0	0	0.0%	5	2	40.0%	5	2	40.0%	6	4	66.7%	3	8	0.0	-12	1	12	52.4%
1/30	UTA	W 109-99	17	16	9	1	0	0	2	1	1	100.0%	4	3	75.0%	5	4	80.0%	9	7	77.8%	3	6	0.5	+12	2	26	89.3%
1/29	DEN	L 107-103	16	7	9	1	0	2	1	0	0	0.0%	5	3	60.0%	5	3	60.0%	2	1	50.0%	5	4	1.0	-12	3	13	59.5%
1/27	PHX	L 106-102	19	7	7	2	0	3	0	0	0	0.0%	5	3	60.0%	5	3	60.0%	2	1	50.0%	3	4	0.0	+5	1	17	59.5%
1/25	LAC	L 126-89	20	8	6	2	1	4	2	0	0	0.0%	5	3	60.0%	5	3	60.0%	3	2	66.7%	2	4	1.0	-7	3	15	63.3%
1/23	BOS	L 130-126	19	5	8	2	0	0	3	0	0	0.0%	3	1	33.3%	3	1	33.3%	4	3	75.0%	4	4	0.7	-4	3	8	52.5%
1/21	NYK	L 120-66	23	6	2	1	0	2	2	2	0	0.0%	3	2	66.7%	5	2	40.0%	2	2	100.0%	1	1	0.5	-36	3	5	51.0%
1/18	CHI	L 124-102	19	5	5	4	0	0	1	0	0	0.0%	3	2	66.7%	3	2	66.7%	2	1	50.0%	3	2	4.0	-18	2	9	64.4%
1/16	CHI	W 112-109	18	14	6	3	0	0	0	0	0	0.0%	8	6	75.0%	8	6	75.0%	2	2	100.0%	1	5	0.0	-4	2	19	78.8%
1/14	NOP	L 116-113	19	15	9	0	0	0	0	0	0	0.0%	9	7	77.8%	9	7	77.8%	2	1	50.0%	3	6	0.0	-5	1	20	75.9%
1/12	DAL	L 113-105	22	14	12	0	1	0	2	0	0	0.0%	7	4	57.1%	7	4	57.1%	6	6	100.0%	7	5	0.0	+2	3	22	72.6%
1/11	MEM	L 103-98	20	8	13	3	1	2	2	0	0	0.0%	7	4	57.1%	7	4	57.1%	0	0	0.0%	6	7	1.5	+5	2	19	57.1%
1/9	LAC	L 121-105	17	6	9	1	0	0	1	2	0	0.0%	4	3	75.0%	6	3	50.0%	0	0	0.0%	4	5	1.0	-1	3	9	50.0%
1/7	ORL	L 104-103	29	5	7	5	0	2	5	0	0	0.0%	4	2	50.0%	4	2	50.0%	2	1	50.0%	4	3	1.0	+7	2	10	51.2%
1/4	DEN	W 127-115	32	17	6	4	1	3	1	1	0	0.0%	8	6	75.0%	9	6	66.7%	8	5	62.5%	1	5	4.0	+17	3	25	67.9%
1/2	WAS	L 119-99	29	14	9	3	2	2	1	1	0	0.0%	11	6	54.5%	12	6	50.0%	3	2	66.7%	4	5	3.0	-13	2	22	52.6%
1/1	HOU	L 120-96	19	8	8	7	0	2	0	1	0	0.0%	5	4	80.0%	6	4	66.7%	0	0	0.0%	3	5	0.0	-2	1	23	66.7%
12/29	GSW	L 120-107	12	3	5	0	0	0	1	2	0	0.0%	1	1	100.0%	3	1	33.3%	2	1	50.0%	1	4	0.0	-14	2	2	38.7%
12/27	MIN	W 123-107	17	10	4	4	0	3	1	0	0	0.0%	5	5	100.0%	5	5	100.0%	0	0	0.0%	0	4	4.0	+21	4	16	100.0%
12/23	PHI	W 114-106	20	9	11	6	0	1	0	1	1	100.0%	4	2	50.0%	5	3	60.0%	2	2	100.0%	5	6	0.0	+16	3	23	76.5%
12/21	TOR	W 96-81	20	8	3	4	0	0	2	0	0	0.0%	4	3	75.0%	4	3	75.0%	2	2	100.0%	0	3	2.0	-2	3	10	82.0%
12/18	MIA	L 106-95	13	4	6	2	0	0	1	2	0	0.0%	2	2	100.0%	4	2	50.0%	0	0	0.0%	3	3	2.0	+1	1	7	50.0%
12/14	MIL	W 127-82	16	10	8	5	0	4	0	0	0	0.0%	6	4	66.7%	6	4	66.7%	2	2	100.0%	2	6	0.0	+14	2	23	72.7%
12/12	DAL	L 119-111	13	6	6	3	1	0	1	0	0	0.0%	3	1	33.3%	3	1	33.3%	4	4	100.0%	2	4	3.0	-5	2	11	63.0%
12/6	NOP	W 119-101	18	16	3	3	1	1	2	0	0	0.0%	8	7	87.5%	8	7	87.5%	3	2	66.7%	1	2	1.5	-6	1	21	85.8%
12/4	UTA	L 123-110	18	10	7	2	1	1	2	1	0	0.0%	6	4	66.7%	7	4	57.1%	4	2	50.0%	4	3	1.0	+6	1	15	57.1%
12/3	CHI	W 113-103	12	5	7	1	2	2	0	0	0	0.0%	3	1	33.3%	3	1	33.3%	3	3	100.0%	1	6	0.0	+5	0	16	57.9%
12/1	CHA	W 116-103	14	6	3	3	0	0	2	1	0	0.0%	3	2	66.7%	4	2	50.0%	4	2	50.0%	1	2	1.5	+3	3	5	52.1%
11/29	MIL	L 116-99	23	7	7	2	1	0	1	2	1	50.0%	4	1	25.0%	6	2	33.3%	6	2	33.3%	1	6	2.0	+9	1	10	40.5%
11/28	PHI	L 115-103	10	3	3	0	0	0	2	1	1	100.0%	3	0	0.0%	4	1	25.0%	0	0	0.0%	2	1	0.0	-4	2	0	37.5%
11/24	NYK	L 113-100	21	5	8	1	0	1	1	1	0	0.0%	3	2	66.7%	4	2	50.0%	2	1	50.0%	2	6	1.0	+4	3	9	51.2%
11/23	TOR	L 119-109	16	5	6	1	0	0	2	0	0	0.0%	2	2	100.0%	2	2	100.0%	4	1	25.0%	1	5	0.5	-4	2	9	66.5%
11/21	BOS	W 113-105	13	4	4	1	1	0	3	0	0	0.0%	2	1	50.0%	2	1	50.0%	3	2	66.7%	1	3	0.3	-10	2	5	60.2%
11/18	BOS	L 113-99	17	16	7	2	0	3	1	2	0	0.0%	8	7	87.5%	10	7	70.0%	3	2	66.7%	3	4	2.0	-4	3	23	70.7%
11/16	WAS	W 129-106	15	6	5	3	0	0	2	0	0	0.0%	4	2	50.0%	4	2	50.0%	2	2	100.0%	1	4	1.5	+9	2	9	61.5%
11/14	ORL	L 105-98	14	4	5	3	0	1	0	1	0	0.0%	3	2	66.7%	4	2	50.0%	0	0	0.0%	2	3	0.0	+3	3	9	50.0%
11/9	NYK	L 134-98	12	10	6	1	1	1	2	0	0	0.0%	3	3	100.0%	3	3	100.0%	4	4	100.0%	5	1	0.5	-14	1	19	105.0%
11/7	DET	L 125-107	17	7	4	3	0	0	3	2	1	50.0%	1	1	100.0%	3	2	66.7%	4	2	50.0%	0	4	1.0	-8	4	6	73.5%
11/5	IND	W 112-103	14	5	7	3	0	0	0	0	0	0.0%	5	1	20.0%	5	1	20.0%	4	3	75.0%	2	5	0.0	+13	0	10	37.0%
11/3	MIN	L 125-109	19	3	7	0	1	2	3	0	0	0.0%	1	1	100.0%	1	1	100.0%	4	1	25.0%	5	2	0.0	-18	2	8	54.3%
11/2	PHI	L 129-105	9	1	2	0	0	1	1	1	0	0.0%	1	0	0.0%	2	0	0.0%	2	1	50.0%	1	1	0.0	-14	0	2	17.4%
10/29	ATL	L 117-112	19	2	6	4	2	1	2	1	0	0.0%	2	1	50.0%	3	1	33.3%	0	0	0.0%	4	2	2.0	-15	1	12	33.3%
10/27	HOU	L 137-109	22	17	12	2	0	0	0	2	1	50.0%	5	5	100.0%	7	6	85.7%	5	4	80.0%	5	7	0.0	-10	4	29	92.4%
10/26	SAS	L 118-107	15	6	3	1	0	2	4	1	0	0.0%	3	3	100.0%	4	3	75.0%	0	0	0.0%	2	1	0.3	+15	4	4	75.0%
10/24	CLE	L 131-124	14	2	2	3	0	1	2	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	0	2	1.5	+6	3	2	50.0%
10/22	CHA	L 136-117	14	14	4	0	2	1	5	2	1	50.0%	5	5	100.0%	7	6	85.7%	2	1	50.0%	1	3	0.0	-13	5	10	88.8%
Regular Season Totals			18.7	8.7	6.7	2.3	0.4	1.1	1.7	0.6	0.1	23.1%	5.1	3.3	64.7%	5.7	3.5	60.1%	2.5	1.7	67.8%	2.8	3.9	1.4	-114	2.4	16.4	63.8%

Day'Ron Sharpe: Breaking News

Sharpe has been diagnosed with an ulnar collateral ligament tear in his left thumb and will require season-ending surgery, Erik Slater of ClutchPoints.com reports. This is a tough blow for Sharpe, who was in the process of putting together one of the best campaigns of his young NBA career. He averaged 8.7 points, 6.7 rebounds, 2.3 assists and 1.1 steals in 62 games. Both Danny Wolf and Josh Minott should be in the mix for backup center minutes with Sharpe sidelined.

Sharpe (thumb) is out for Thursday's game against the Hawks. Sharpe will be sidelined for the second straight game Thursday. With this news, more minutes will be up for grabs for players like Danny Wolf and Ochai Agbaji.

Sharpe won't play in Tuesday's game against Detroit due to a left thumb sprain, per Brian Lewis of the New York Post. Sharpe is sitting out for the first time since the Jan. 19 loss to the Suns. Danny Wolf and Ochai Agbaji should both see more playing time in the frontcourt in the absence of Sharpe on Tuesday.